The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Glenmark shares on Monday ended 0.68% up at ₹1,600.85 apiece on BSE. New Delhi: Glenmark Pharmaceuticals on Monday said it will launch cancer treatment drug zanubrutinib in India following approval by ...

Samsung Bioepis announced on the 1st that it will launch the osteoporosis treatment for menopausal women, Obodence ...

Low magnesium can lead to muscle cramps, insomnia, and fatigue. Seniors should aim for about 320 mg for women and 420 mg for men daily, either through magnesium-rich foods or a gentle supplement like ...

He is currently taking naproxen 250 mg twice daily, ezetimibe 10 mg, and metformin 1000 mg twice daily for his medications. Three years ago, he was started on atorvastatin 20 mg daily to treat his ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Metformin and lifestyle intervention was associated with delayed type 2 diabetes onset and slower diabetes progression than placebo.

Metformin should not be used to treat type 1 diabetes. “I cannot stress enough that metformin is not a primary weight loss medication,” adds Dr. Schmidt.